跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
陳 文昭
主治醫師
,
臺北醫學大學附設醫院
成員
,
臺北醫學大學消化醫學研究中心
https://orcid.org/0000-0001-5543-1690
電子郵件
143007
h.tmu.edu
tw
h-index
59
引文
4
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
2020
2022
每年研究成果
概覽
指紋
網路
研究成果
(5)
類似的個人檔案
(7)
指紋
查看啟用 Wen-Chao Chen 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Inflammation
100%
Inflammatory Pain
47%
Intestine Flora
47%
Dextran Sulfate Sodium-Induced Colitis
47%
Cholecystitis
47%
Cholelithiasis
47%
Polysaccharide
47%
Inflammatory Bowel Disease
47%
Fucus vesiculosus
47%
Capsaicin
47%
Ascophyllum
47%
Hyperlipidemia
47%
Gallstone
47%
Lycium barbarum
47%
Mouse
38%
Ulcerative Colitis
31%
Antilipemic Agent
31%
Pancreatic Lipase
31%
Interleukin 6
31%
Tumor Necrosis Factor
26%
Dextran Sulfate
21%
Receptor
21%
Ankyrin
21%
Superoxide Dismutase
21%
Polyphenol
15%
Aspartate Aminotransferase
15%
Alanine Aminotransferase
15%
Fatty Acid
15%
Pharmacological Activity
15%
Glutathione Peroxidase
15%
High Density Lipoprotein Cholesterol
15%
Drug
15%
Rat Model
15%
Marine Alga
15%
Metabolic Syndrome X
15%
Atherosclerosis
15%
Peroxidase
15%
Transient Receptor Potential Channel
15%
Symptom
15%
2,4,6-Trinitrobenzenesulfonic Acid
14%
Acute Cholecystitis
11%
Disease
11%
Catalase
10%
Anti-Inflammatory Drug
9%
Probiotic Agent
9%
Dysbiosis
9%
Abdominal Pain
5%
Absence
5%
Clinical Trial
5%
Inflammatory Disease
5%
Immunology and Microbiology
Extract
47%
Akkermansia muciniphila
47%
Fucus vesiculosus
47%
Intestine Flora
47%
Ascophyllum
47%
Inflammatory Bowel Disease
47%
Lipid Metabolism
47%
Mouse
38%
Superoxide
23%
Marine Alga
23%
Adipocyte
23%
Fatty Acid Level
23%
Insulin Blood Level
23%
Rat Model
23%
Cholesterol Blood Level
23%
Interleukin 6
23%
High Density Lipoprotein Cholesterol Level
23%
Tumor Necrosis Factor Alpha
23%
Atherosclerosis
23%
Epididymis
23%
Probiotic
9%
Akkermansia
9%
Medicine and Dentistry
Akkermansia muciniphila
47%
Gut Microbiota
47%
Inflammatory Bowel Disease
47%
Trinitrobenzenesulfonic Acid
14%
Probiotic Agent
9%
Dysbiosis
9%
Akkermansia
9%
Anti-Inflammatory Drug
9%